This Article Full Text (PDF) HTML Page - index.htslp References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Stief, T. W. Articles by Fareed, J. Search for Related Content PubMed PubMed Citation Articles by Stief, T. W. Articles by Fareed, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB OXYGEN Social Bookmarking                         What's this?

State-of-the-Art-Review : The Antithrombotic Factor Singlet Oxygen/Light (1O2/hv)

Department of Clinical Chemistry, Philipps University, Marburg, Germany

Jawed Fareed, Ph.D.

Loyola University Medical Center, Chicago-Maywood, IL, USA

Activated phagocytes (especially polymorpho nuclear granulocytes (PMNs)) by respiratory oxidative/ photonic burst (activation of NADPH-oxidase and myeloper oxidase) generate large amounts of oxidants of the hypochlo rite-/chloramine-type, which are physiologic sources for singlet oxygen (¹O₂), a nonradical-excited (photon (h) emitting) oxy gen species [Weiss SJ, NEJM 1989;320:365-376]. In vitro ex periments show that ¹O₂ (1) inhibits coagulation by inactiva tion of thrombocytes, fibrinogen, factor V, factor VIII, and factor X and (2) activates fibrinolysis by inactivation of the main fibrinolysis inhibitors plasminogen activator inhibitor (PAI)-1 and alpha-2-antiplasmin, and by activation of single- chain urokinase by plasmin and oxidized fibrin. Additionally, this work suggests that ¹O₂/h acts antithrombotically, induc ing selective thrombolysis in vivo (i.e., thrombolysis induced by 0.1 to 0.5 mmol/l chloramine within 30 to 60 minutes with out changes of the plasmatic hemostasis system). ¹O₂ might activate flowing to (on the endothelium) rolling PMN, increas ing their chance to get in contact with fibrin/platelet aggregates deposited on the endothelial layer. Via ¹O₂ generation, the thrombus-activated phagocytes might call for (acute, physi ologic) inflammation/fibrinolysis amplification, resulting in the "moving front" of PMN, which infiltrates and destroys the thrombus. ¹O₂ seems to (partially) participate in the reactivity of nitric oxide, another prooxidative agent. The inhibition of physiologic amounts of ¹O₂ by blood cholesterol might be in volved in the pathogenesis of atherothrombosis. Consequently, it is suggested that activated PMNs modulate hemostasis, shift ing it into an antithrombotic state; this cellular part of fibrino lysis seems to be of greater physiologic importance than the plasmatic one. Impaired PMN function (e.g., as occurring in patients with antineutrophil cytoplasmic antibodies or under cytostatic treatments) often results in serious thrombotic com plications. Light is the only signal whose origin can be imme diately recognized by a fast moving cell in the (dark) blood stream. The cell signal action of ¹O₂/h (e.g., released by chlo ramines such as taurine-chloramine or vancomycin, by fiber- optic, by photodynamic therapy, or by so-called redox-cycling drugs such as quinones or tetracyclines) might be a new and physiologic principle for pharmacologic intervention in athero thrombosis.

Key Words: Key words: Singlet oxygen • Light • Phagocytes • Neutrophils • Hemostasis • Thrombolysis • Anticoagulation

Clinical and Applied Thrombosis/Hemostasis, Vol. 6, No. 1, 22-30 (2000)
DOI: 10.1177/107602960000600104


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				T. W. Stief Singlet Oxygen Enhances Intrinsic Thrombolysis: The Intrinsic Oxidative Clot Lysis Assay (INOXCLA) Clinical and Applied Thrombosis/Hemostasis, October 1, 2007; 13(4): 369 - 383. [Abstract] [PDF]

				T. W. Stief Singlet Oxygen Potentiates Thrombolysis Clinical and Applied Thrombosis/Hemostasis, July 1, 2007; 13(3): 259 - 278. [Abstract] [PDF]

				T. W. Stief The Fibrinogen Antigenic Turbidimetric Assay (FIATA): The X2x Test--The Corrected Chi-Square Comparison Against the Control-mean Clinical and Applied Thrombosis/Hemostasis, January 1, 2007; 13(1): 73 - 100. [Abstract] [PDF]

				T. W. Stief, A. Richter, R. Bunder, B. Maisch, and H. Renz Monitoring of Plasmin and Plasminogen Activator Activity in Blood of Patients under Fibrinolytic Treatment by Reteplase Clinical and Applied Thrombosis/Hemostasis, April 1, 2006; 12(2): 213 - 218. [Abstract] [PDF]

				T. Stief G-CSF Enhances Cellular Fibrinolysis Clinical and Applied Thrombosis/Hemostasis, January 1, 2006; 12(1): 122 - 122. [PDF]

				T. W. Stief, R. Buinder, A. Richter, B. Maisch, H. Renz, and J. Fareed In vitro Simulation of Therapeutic Plasmatic Fibrinolysis Clinical and Applied Thrombosis/Hemostasis, July 1, 2003; 9(3): 211 - 220. [Abstract] [PDF]

				T. W. Stief, O. Herkert, I. Diebold, R. P. Brandes, R. Busse, J. Hess, and A. Gorlach NADPH-Oxidase Might Also Act as an Antithrombotic * Response Circulation, January 7, 2003; 107 (1): e8 - e8. [Full Text] [PDF]

				T.W. Stief, W.P. Jeske, J. Walenga, C. Schultz, V. Kretschmer, and J. Fareed Singlet Oxygen Inhibits Agonist-Induced P-Selectin Expression and Formation of Platelet Aggregates Clinical and Applied Thrombosis/Hemostasis, July 1, 2001; 7(3): 219 - 224. [Abstract] [PDF]